148 related articles for article (PubMed ID: 20848533)
1. Bacterial induction of proinflammatory cytokines in inflammatory bowel disease.
Klapproth JM; Sasaki M
Inflamm Bowel Dis; 2010 Dec; 16(12):2173-9. PubMed ID: 20848533
[TBL] [Abstract][Full Text] [Related]
2. Alterations of the mucosal immune system in inflammatory bowel disease.
MacDermott RP
J Gastroenterol; 1996 Dec; 31(6):907-16. PubMed ID: 9027661
[TBL] [Abstract][Full Text] [Related]
3. Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance.
Caradonna L; Amati L; Magrone T; Pellegrino NM; Jirillo E; Caccavo D
J Endotoxin Res; 2000; 6(3):205-14. PubMed ID: 11052175
[TBL] [Abstract][Full Text] [Related]
4. The regulation and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells.
Panja A; Goldberg S; Eckmann L; Krishen P; Mayer L
J Immunol; 1998 Oct; 161(7):3675-84. PubMed ID: 9759892
[TBL] [Abstract][Full Text] [Related]
5. Cytokine production profile in intestinal mucosa of paediatric inflammatory bowel disease.
Vitale S; Strisciuglio C; Pisapia L; Miele E; Barba P; Vitale A; Cenni S; Bassi V; Maglio M; Del Pozzo G; Troncone R; Staiano A; Gianfrani C
PLoS One; 2017; 12(8):e0182313. PubMed ID: 28797042
[TBL] [Abstract][Full Text] [Related]
6. Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease.
Cătană CS; Berindan Neagoe I; Cozma V; Magdaş C; Tăbăran F; Dumitraşcu DL
World J Gastroenterol; 2015 May; 21(19):5823-30. PubMed ID: 26019446
[TBL] [Abstract][Full Text] [Related]
7. IL-17A alone weakly affects the transcriptome of intestinal epithelial cells but strongly modulates the TNF-α-induced expression of inflammatory mediators and inflammatory bowel disease susceptibility genes.
Friedrich M; Diegelmann J; Beigel F; Brand S
Inflamm Bowel Dis; 2014 Sep; 20(9):1502-15. PubMed ID: 25105947
[TBL] [Abstract][Full Text] [Related]
8. Role of cytokines in the pathogenesis of inflammatory bowel disease.
Papadakis KA; Targan SR
Annu Rev Med; 2000; 51():289-98. PubMed ID: 10774465
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases.
Sartor RB
Am J Gastroenterol; 1997 Dec; 92(12 Suppl):5S-11S. PubMed ID: 9395346
[TBL] [Abstract][Full Text] [Related]
10. Review of natural products actions on cytokines in inflammatory bowel disease.
Hur SJ; Kang SH; Jung HS; Kim SC; Jeon HS; Kim IH; Lee JD
Nutr Res; 2012 Nov; 32(11):801-16. PubMed ID: 23176791
[TBL] [Abstract][Full Text] [Related]
11. Monocyte and M1 Macrophage-induced Barrier Defect Contributes to Chronic Intestinal Inflammation in IBD.
Lissner D; Schumann M; Batra A; Kredel LI; Kühl AA; Erben U; May C; Schulzke JD; Siegmund B
Inflamm Bowel Dis; 2015 Jun; 21(6):1297-305. PubMed ID: 25901973
[TBL] [Abstract][Full Text] [Related]
12. New mediators of immunity and inflammation in inflammatory bowel disease.
Monteleone G; Fina D; Caruso R; Pallone F
Curr Opin Gastroenterol; 2006 Jul; 22(4):361-4. PubMed ID: 16760750
[TBL] [Abstract][Full Text] [Related]
13. [The role of mast cells in the development of inflammatory bowel diseases].
Wierzbicki M; Brzezińska-Błaszczyk E
Postepy Hig Med Dosw (Online); 2008 Nov; 62():642-50. PubMed ID: 19037190
[TBL] [Abstract][Full Text] [Related]
14. Wip 1 inhibits intestinal inflammation in inflammatory bowel disease.
Zhang Q; Zhang C; Chang F; Liang K; Yin X; Li X; Zhao K; Niu Q; Tian Z
Cell Immunol; 2016 Dec; 310():63-70. PubMed ID: 27687530
[TBL] [Abstract][Full Text] [Related]
15. Intestinal epithelial cell regulation of mucosal inflammation.
Yu Y; Sitaraman S; Gewirtz AT
Immunol Res; 2004; 29(1-3):55-68. PubMed ID: 15181270
[TBL] [Abstract][Full Text] [Related]
16. Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease.
Shioya M; Nishida A; Yagi Y; Ogawa A; Tsujikawa T; Kim-Mitsuyama S; Takayanagi A; Shimizu N; Fujiyama Y; Andoh A
Clin Exp Immunol; 2007 Sep; 149(3):480-6. PubMed ID: 17590175
[TBL] [Abstract][Full Text] [Related]
17. The Intestinal Microbiota in Inflammatory Bowel Disease.
Becker C; Neurath MF; Wirtz S
ILAR J; 2015; 56(2):192-204. PubMed ID: 26323629
[TBL] [Abstract][Full Text] [Related]
18. The effect of probiotics and gut microbiota on Th17 cells.
Tanabe S
Int Rev Immunol; 2013; 32(5-6):511-25. PubMed ID: 24094077
[TBL] [Abstract][Full Text] [Related]
19. Metabolome and inflammasome in inflammatory bowel disease.
Nanau RM; Neuman MG
Transl Res; 2012 Jul; 160(1):1-28. PubMed ID: 22687960
[TBL] [Abstract][Full Text] [Related]
20. Cytokines in inflammatory bowel disease.
Kmieć Z
Arch Immunol Ther Exp (Warsz); 1998; 46(3):143-55. PubMed ID: 9704146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
